Zidovudine dosage. Nordic Medical Research Councils' HIV Therapy Group.
作者信息
Gøtzsche P
出版信息
BMJ. 1993 Sep 11;307(6905):682-3. doi: 10.1136/bmj.307.6905.682-b.
Abstract
摘要
相似文献
1
Zidovudine dosage. Nordic Medical Research Councils' HIV Therapy Group.齐多夫定剂量。北欧医学研究理事会艾滋病治疗小组。
BMJ. 1993 Sep 11;307(6905):682-3. doi: 10.1136/bmj.307.6905.682-b.
2
[Double-blind dose-response study of zidovudine in AIDS and advanced HIV infection. Nordic Medical Research Councils' HIV Therapy Group].
Ugeskr Laeger. 1993 Jan 11;155(2):104-7.
3
Double blind dose-response study of zidovudine in AIDS and advanced HIV infection. Nordic Medical Research Councils' HIV Therapy Group.齐多夫定治疗艾滋病和晚期HIV感染的双盲剂量反应研究。北欧医学研究委员会HIV治疗组。
BMJ. 1992 Jan 4;304(6818):13-7. doi: 10.1136/bmj.304.6818.13.
4
FDA Committee recommends clearance for HIVID combination therapy.美国食品药品监督管理局委员会建议批准HIVID联合疗法。
AIDS Patient Care STDS. 1996 Jun;10(3):186.
5
A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection. Results of the Veterans Affairs Cooperative Study.齐多夫定早期与晚期治疗有症状人类免疫缺陷病毒感染的对照试验。退伍军人事务部合作研究结果。
N Engl J Med. 1992 Feb 13;326(7):437-43. doi: 10.1056/NEJM199202133260703.
6
7
Effectiveness of zidovudine in treatment of advanced HIV infection.齐多夫定治疗晚期HIV感染的疗效
JAMA. 1994 Apr 13;271(14):1121-2.
8
Zidovudine: clinical experience in symptomatic HIV disease.齐多夫定：有症状HIV疾病的临床经验。
AIDS Clin Rev. 1989:221-42.
9
A new HIV/AIDS drug.
J Ark Med Soc. 1996 Jan;92(8):407.
10
A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy.茚地那韦、齐多夫定和拉米夫定用于接受过抗逆转录病毒治疗的晚期1型人类免疫缺陷病毒感染成人患者的随机对照试验。
J Infect Dis. 1999 Sep;180(3):659-65. doi: 10.1086/314948.
引用本文的文献
1
Zidovudine dosage.齐多夫定剂量。
BMJ. 1993 Nov 27;307(6916):1423. doi: 10.1136/bmj.307.6916.1423-b.
2
Pharmacokinetic optimisation of antiretroviral therapy in patients with HIV infection.HIV感染患者抗逆转录病毒治疗的药代动力学优化
Clin Pharmacokinet. 1995 Jul;29(1):46-65. doi: 10.2165/00003088-199529010-00006.
本文引用的文献
1
A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group.
N Engl J Med. 1990 Oct 11;323(15):1009-14. doi: 10.1056/NEJM199010113231501.
2
Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.齐多夫定用于无症状人类免疫缺陷病毒感染。对每立方毫米CD4阳性细胞少于500个的患者进行的对照试验。美国国立过敏与传染病研究所艾滋病临床试验组。
N Engl J Med. 1990 Apr 5;322(14):941-9. doi: 10.1056/NEJM199004053221401.
Zotero 插件